Filing Flows › Bristol Myers Squibb (BMY) › Q2 2026
Bristol Myers Squibb (BMY) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 30, 2026
Bristol Myers Squibb (BMY) reported revenue of $13.0B for the second quarter 2026 (Q2 2026), +6% from a year earlier and +13% from the quarter before. Operating margin was 31.5%, net earnings $3.3B (25.6% of revenue).
Bristol Myers Squibb, Q2 2026: revenue $13.0B (+6% year over year), operating margin 31.5%, net earnings $3.3B, operating cash flow $3.4B. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $13.0B | +13% | +6% |
| Operating profit | $4.1B | +26% | +130% |
| Net earnings | $3.3B | +24% | +153% |
| Operating cash flow | $3.4B | +207% | -13% |
| Free cash flow | $3.1B | +308% | -13% |
What changed
Revenue was $13.0B in Q2 2026, up 6% year over year and up 13% from the previous quarter. Legacy Portfolio was the largest line at 42% of revenue. Eliquis added $0.80B year over year (up 22%), 114% of the total change. Revlimid declined 49%.
Operating profit was $4.1B, a 31.5% margin (up 17.0 points year over year). Of the extra revenue versus Q2 2025, 329% reached operating profit, above the 14% margin then. Total costs fell 15% while revenue rose 6%. The fastest-growing cost line was Research & development (+15%). Net earnings were $3.3B, up 153% year over year. The effective tax rate was 18.8%.
Operating cash flow was $3.4B (down 13% year over year), 102% of net earnings. Non-cash charges added back $0.59B of depreciation and amortization and $0.14B of share-based compensation. Working capital and other items used $0.65B. Capital expenditures of $0.30B left free cash flow of $3.1B.
Questions
What was Bristol Myers Squibb's revenue in the second quarter 2026?
Bristol Myers Squibb (BMY) reported revenue of $13.0B for the second quarter 2026 (Q2 2026), +6% from a year earlier and +13% from the quarter before.
Was Bristol Myers Squibb profitable in the second quarter 2026?
Operating profit was $4.1B (31.5% of revenue) and net earnings $3.3B.